Phosphatidylcholine as a precursor of choline for acetylcholine synthesis
- PMID: 3316498
Phosphatidylcholine as a precursor of choline for acetylcholine synthesis
Abstract
It has been hypothesized that the selective vulnerability of certain brain cholinergic neurons in Alzheimer's disease may reflect the unique way that choline is utilized by these neurons, i.e. not only as a component of major membrane phospholipids, e.g. phosphatidylcholine (PC), but also as a precursor of their neurotransmitter, acetylcholine (ACh). A prolonged utilization of choline liberated from PC, for ACh production, without adequate resynthesis of this lipid, might result in a net loss of the phosphatide followed by an impairment of membrane function and loss of cellular viability. Studies described in this paper, performed on electrically stimulated striatal slices and on cholinergic cell lines, test this hypothesis. 1) Electrically-stimulated striatal slices continue to release ACh, and sustain their free choline and ACh levels, even when perfused with a choline-free medium. Striatal levels of PC decline under these circumstances, and this decline can be blocked by adding tetrodotoxin (which blocks neuronal depolarization) or choline to the medium. The other major membrane phospholipids, phosphatidylserine and phosphatidylethanolamine, also decline proportionately to PC when slices are stimulated in the absence of choline. 2) In a population of purely cholinergic cells (human neuroblastoma, LA-N-2), ACh can be synthesized from choline derived from degradation of endogenous PC formed de novo by methylation of phosphatidylethanolamine. 3) PC content of cells in culture (neuroblastoma X glioma hybrid, NG 108-15) can be altered by adding various amounts of choline to the growth media. The proportion of PC in the cells apparently affects cellular survival and rate of growth. Taken together these data demonstrate that cholinergic neurons utilize the choline stored in PC to synthesize ACh; that this process may lead to a depletion in membrane phospholipids (when choline supply is inadequate); and that the resulting changes in neuronal membrane composition might adversely affect cellular viability.
Similar articles
-
Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum.Brain Res. 1989 Apr 10;484(1-2):217-27. doi: 10.1016/0006-8993(89)90364-8. Brain Res. 1989. PMID: 2713682
-
Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line.Proc Natl Acad Sci U S A. 1987 Aug;84(15):5474-7. doi: 10.1073/pnas.84.15.5474. Proc Natl Acad Sci U S A. 1987. PMID: 3474663 Free PMC article.
-
Acetylcholine synthesis and release in NIH3T3 cells coexpressing the high-affinity choline transporter and choline acetyltransferase.J Neurosci Res. 2009 Oct;87(13):3024-32. doi: 10.1002/jnr.22117. J Neurosci Res. 2009. PMID: 19405101
-
[Regulation of acetylcholine synthesis in presynaptic endings of cholinergic neurons of the central nervous system].Neirofiziologiia. 1984;16(5):603-11. Neirofiziologiia. 1984. PMID: 6151119 Review. Russian.
-
Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction.Curr Med Chem. 2008;15(5):488-98. doi: 10.2174/092986708783503203. Curr Med Chem. 2008. PMID: 18289004 Review.
Cited by
-
Effect of acute thioacetamide administration on rat brain phospholipid metabolism.Neurochem Res. 1990 Sep;15(9):927-31. doi: 10.1007/BF00965914. Neurochem Res. 1990. PMID: 2274104
-
Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.Psychopharmacology (Berl). 2009 Jan;202(1-3):37-51. doi: 10.1007/s00213-008-1351-0. Epub 2008 Oct 14. Psychopharmacology (Berl). 2009. PMID: 18853146 Review.
-
The orphan transporter v7-3 (slc6a15) is a Na+-dependent neutral amino acid transporter (B0AT2).Biochem J. 2006 Jan 1;393(Pt 1):421-30. doi: 10.1042/BJ20051273. Biochem J. 2006. PMID: 16185194 Free PMC article.
-
Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion.Alzheimers Dement. 2015 Oct;11(10):1153-62. doi: 10.1016/j.jalz.2014.10.011. Epub 2014 Dec 10. Alzheimers Dement. 2015. PMID: 25496873 Free PMC article.
-
No Acute Effects of Choline Bitartrate Food Supplements on Memory in Healthy, Young, Human Adults.PLoS One. 2016 Jun 24;11(6):e0157714. doi: 10.1371/journal.pone.0157714. eCollection 2016. PLoS One. 2016. PMID: 27341028 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources